Clinical Trials on 急性髓性白血病 in Korea, Democratic People's Republic of
总计843个结果
-
Seoul National University HospitalPharos iBio Co., Ltd.招聘中
-
Samsung Medical Center未知
-
Samsung Medical Center未知
-
Konkuk University Medical CenterChonbuk National University Hospital; Samsung Medical Center; Pusan National University Hospital; Seoul National University Hospital 和其他合作者主动,不招人
-
Ulsan University HospitalThe Korean Society of Hematology, AML/MDS Working Party未知
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology未知
-
Cooperative Study Group A for Hematology未知
-
Ulsan University HospitalThe Korean Society of Hematology CML working party未知
-
Samsung Medical CenterJin Yang Pharmaceutical暂停
-
Asan Medical CenterKorea Research Institute of Bioscience & Biotechnology完全的
-
Asan Medical Center主动,不招人
-
JW Pharmaceutical主动,不招人
-
The Korean Society of Blood and Marrow TransplantationChonbuk National University Hospital; Samsung Medical Center; Seoul St. Mary's Hospital; Pusan National... 和其他合作者终止
-
Korea Otsuka Pharmaceutical Co., Ltd.主动,不招人
-
Seoul National University Hospital招聘中
-
Seoul St. Mary's HospitalJanssen, LP未知
-
Asan Medical Center完全的
-
Asan Medical Center终止白血病,慢性粒细胞 | 骨髓性白血病,慢性,慢性期 | 骨髓性白血病,慢性,加速期大韩民国
-
Astellas Pharma Korea, Inc.招聘中具有 FMS 样酪氨酸激酶 (FLT3) 突变的急性髓性白血病大韩民国
-
Institut de Recherches Internationales ServierADIR, a Servier Group company招聘中
-
Otsuka Pharmaceutical Co., Ltd.Korea Otsuka Pharmaceutical Co., Ltd.完全的
-
Seoul St. Mary's HospitalBristol-Myers Squibb未知
-
Novartis Pharmaceuticals完全的
-
Novartis Pharmaceuticals主动,不招人急性髓系白血病 (AML) | 多发性骨髓瘤 (MM) | 非霍奇金淋巴瘤 (NHL)比利时, 意大利, 大韩民国, 香港, 以色列, 芬兰, 西班牙, 日本, 美国
-
Seoul St. Mary's HospitalNovartis未知